ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Complementary Medicine Meets Rheumatology: New Ways to Reduce Inflammation

Ruth Jessen Hickman, MD  |  November 14, 2025

At this ACR Convergence 2025 session, the speaker highlighted ways complementary and alternative medicine can be used alongside traditional medical treatments.

Filed under:ACR ConvergenceMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAComplementary and Alternative TherapiesDietstress managementsupplements

ARP Year in Review: Updates in Advanced Practice, Epidemiology & Rehabilitation

Catherine Kolonko   |  November 12, 2025

Three experts discussed recent notable research of interest to rheumatology professionals across a range of topics.

Filed under:ACR ConvergenceConditionsMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:ACR Convergence 2025Association of Rheumatology Professionals (ARP)OsteoarthritisResearch

Secrets & Pearls of Rheumatology at ACR Convergence 2025

Mithu Maheswaranathan, MD  |  November 12, 2025

Two clinical diagnosticians presented their pearls of wisdom for clinical rheumatologists to take forward when managing patients from the clinics to the hospital wards.

Filed under:ACR ConvergenceMeeting ReportsMyositisOther Rheumatic ConditionsSjögren’s DiseaseSystemic Lupus ErythematosusVasculitis Tagged with:ACR Convergence 2025ACR Convergence 2025 - LNconnective tissue diseaseLupusLupus nephritismyositisRaynaud’s phenomenonRheumatic DiseaseSjögren's Diseasesystemic lupus erythematosus (SLE)

Rheuminations: Address Ableism, Improve Care for All Patients

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  November 10, 2025

Ableism—discrimination against those with disabilities—distorts diagnostic reasoning & erodes patient trust. How can rheumatologists address this bias?

Filed under:EthicsOpinionRheuminations Tagged with:ableismAccess to carecommunicationdisabilityhealth disparitiespatient-centered care

ACR Advocacy Update 2025, Federal & State

Mary Beth Nierengarten  |  November 9, 2025

ACR representatives outlined its 2025 legislative priorities, including fixing the MPFS, reforming prior authorization & protecting telehealth reimbursement.

Filed under:ACR ConvergenceFrom the College Tagged with:ACR Convergence 2025AdvocacyCongressLegislation & AdvocacyMedicaidMedicare ReimbursementPhysician fee scheduletelehealthvaccine

President’s Corner: Dr. Langford’s Reflections on the ACR’s 2025

Carol A. Langford, MD, MHS  |  November 5, 2025

Dr. Langford’s final column reflects on 2025’s advocacy, challenges & member teamwork. Click through to read the outgoing ACR president’s parting thoughts.

Filed under:From the CollegeLegislation & AdvocacyPresident's Perspective Tagged with:AdvocacyGovernment Affairs CommitteeLeadershipPresident's CornerRheumPACVolunteeryear in review

The Intersection of Immunology & Rheumatology

Mary Beth Nierengarten  |  November 5, 2025

The winning case study in this year’s Thieves Market highlight a case study from Malaysia with a patient who initially presented with seronegative inflammatory arthritis but experienced recurrent infections and had a porcelain aorta.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2025Bruton’s diseaseX-linked Agammaglobulinemia

Does High-Intensity Interval Training Lower Inflammatory Disease Activity?

Kurt Ullman  |  November 4, 2025

Experts discuss high-intensity interval training as an underused “disease-modifying drug” for inflammatory diseases. Learn how to safely integrate it into patient treatment plans.

Filed under:ACR ConvergenceConditionsPsoriatic ArthritisRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - PsAACR Convergence 2025 - RADisease Activity Score (DAS)ExercisefatigueFlaresHIITInflammatory Diseasephysical activity

Calcium Pyrophosphate Deposition Disease Diagnosis & Treatment Gaps Remain

Kurt Ullman  |  November 3, 2025

CPPD diagnosis is difficult & treatments are limited. Experts review radiology challenges, off-label options like colchicine, & emerging biologics.

Filed under:ACR ConvergenceConditionsGout and Crystalline ArthritisGuidanceOsteoarthritis and Bone DisordersResearch Rheum Tagged with:ACR Convergence 2025calcium pyrophosphate deposition diseasechondrocalcinosisColchicinecrystal arthritisprednisonepseudogout

How Lymphatic Drainage Controls Synovial Inflammation

Michael Cammarata, MD  |  November 2, 2025

Why do lymphatics fail in inflammatory arthritis? Research from ACR Convergence 2025 points to a network of telocytes & mast cells that control synovial drainage.

Filed under:ACR ConvergenceConditionsMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAlymphaticsmast cellsynovitistelocytes

  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 336
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences